CD0271 0.1% Gel
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD0271 0.1% Gel, covering 2016-11-03 to 2016-11-03. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety Study of GK530G Versus CD0271 0.1% Gel and CD1579 2.5% Gel in the Treatment of Acne Vulgaris. [Phase 3]